Screener
Aclaris Therapeutics ACRS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's current ratio?
- Aclaris Therapeutics (ACRS) reported current ratio of 3.5× in Q2 2026.
- How has Aclaris Therapeutics's current ratio changed year-over-year?
- Aclaris Therapeutics's current ratio decreased by 10.8% year-over-year, from 3.9× to 3.5×.
- What is the long-term trend for Aclaris Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's current ratio has grown at a -2.7% compound annual growth rate (CAGR), from 3.9× to 3.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Aclaris Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude